Antidiabetics Market Updates by 2031
Antidiabetic is commonly used to manage diabetes with the help of antidiabetic agent. Antidiabetic agent is a substance that help a person with diabetes control their level of glucose (sugar) in the blood. It include insulin and hypoglycemic agent.
MARKET DYNAMICS
The antidiabetics market is expected to grow during the forecast period due to the changing life style and consumption of unhealthy food is increasing globally diabetes disease. Rising incidence of diabetes will result into substantial rise in demand for antidiabetic. Growing R&D activities is likely to show positive impact on market growth. Raising awareness of treatment is one of the biggest opportunity for antidiabetics market in the emerging nations.
MARKET SCOPE
The "Global Antidiabetics Market Analysis to 2031" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of antidiabetics market with detailed market segmentation by product type, drug class, and geography. The global antidiabetics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading antidiabetics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global antidiabetics market is segmented on the basis of product, patient and route of administration. Based on products, the market is segmented as insulin and drug class. On the basis of patient, the global antidiabetics market is classify into pediatric, adult and geriatric. Based on route of administration, the market segmented into insulin pump, insulin syringe or insulin pen, intravenous infusion, oral and others.
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global antidiabetics market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antidiabetics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting antidiabetics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antidiabetics market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global antidiabetics market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antidiabetics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting antidiabetics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antidiabetics market in these regions.
MARKET PLAYERSThe reports cover key developments in the antidiabetics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from antidiabetics market are anticipated to lucrative growth opportunities in the future with the rising demand for antidiabetics market in the global market. Below mentioned is the list of few companies engaged in the antidiabetics market.
The report also includes the profiles of key antidiabetics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Johnson & Johnson
- Bayer Corporation AG
- AstraZeneca
- Sanofi
- Novartis AG
- Bristol-Myers Squibb Company
- Merck & Co., Inc.
- Eli Lilly and Company
- Pfizer Inc.
- Novo Nordisk
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antidiabetics Market - By Product
1.3.2 Antidiabetics Market - By Patient
1.3.3 Antidiabetics Market - By Route of Administration
1.3.4 Antidiabetics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIDIABETICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIDIABETICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ANTIDIABETICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIDIABETICS - GLOBAL MARKET OVERVIEW
6.2. ANTIDIABETICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIDIABETICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSULIN
7.3.1. Overview
7.3.2. Insulin Market Forecast and Analysis
7.3.3. Rapid Acting Analog Market
7.3.3.1. Overview
7.3.3.2. Rapid Acting Analog Market Forecast and Analysis
7.3.4. Long Acting Analog Market
7.3.4.1. Overview
7.3.4.2. Long Acting Analog Market Forecast and Analysis
7.3.5. Premixed Insulin Market
7.3.5.1. Overview
7.3.5.2. Premixed Insulin Market Forecast and Analysis
7.3.6. Short Acting Analog Market
7.3.6.1. Overview
7.3.6.2. Short Acting Analog Market Forecast and Analysis
7.3.7. Intermediate Acting insulin Market
7.3.7.1. Overview
7.3.7.2. Intermediate Acting insulin Market Forecast and Analysis
7.4. DRUG CLASS
7.4.1. Overview
7.4.2. Drug Class Market Forecast and Analysis
7.4.3. Alpha Glucosidase Inhibitors Market
7.4.3.1. Overview
7.4.3.2. Alpha Glucosidase Inhibitors Market Forecast and Analysis
7.4.4. Biguanides Market
7.4.4.1. Overview
7.4.4.2. Biguanides Market Forecast and Analysis
7.4.5. Sulphonylureas Market
7.4.5.1. Overview
7.4.5.2. Sulphonylureas Market Forecast and Analysis
7.4.6. GLP-1 (Glucagon like Peptide) Agonists Market
7.4.6.1. Overview
7.4.6.2. GLP-1 (Glucagon like Peptide) Agonists Market Forecast and Analysis
7.4.7. DPP-IV (Dipeptidyl Peptidase) Inhibitors Market
7.4.7.1. Overview
7.4.7.2. DPP-IV (Dipeptidyl Peptidase) Inhibitors Market Forecast and Analysis
7.4.8. Meglitinides Market
7.4.8.1. Overview
7.4.8.2. Meglitinides Market Forecast and Analysis
7.4.9. SGLT-II (Sodium Glucose Transport Proteins) Inhibitors Market
7.4.9.1. Overview
7.4.9.2. SGLT-II (Sodium Glucose Transport Proteins) Inhibitors Market Forecast and Analysis
7.4.10. Thiazolidinedione Market
7.4.10.1. Overview
7.4.10.2. Thiazolidinedione Market Forecast and Analysis
8. ANTIDIABETICS MARKET - REVENUE AND FORECASTS TO 2028 - PATIENT
8.1. OVERVIEW
8.2. PATIENT POPULATION MARKET FORECASTS AND ANALYSIS
8.3. PEDIATRIC
8.3.1. Overview
8.3.2. Pediatric Market Forecast and Analysis
8.4. ADULT
8.4.1. Overview
8.4.2. Adult Market Forecast and Analysis
8.5. GERIATRIC
8.5.1. Overview
8.5.2. Geriatric Market Forecast and Analysis
9. ANTIDIABETICS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. INSULIN PUMP
9.3.1. Overview
9.3.2. Insulin Pump Market Forecast and Analysis
9.4. INSULIN SYRINGE/ INSULIN PEN
9.4.1. Overview
9.4.2. Insulin Syringe/ Insulin Pen Market Forecast and Analysis
9.5. INTRAVENOUS INFUSION
9.5.1. Overview
9.5.2. Intravenous Infusion Market Forecast and Analysis
9.6. ORAL
9.6.1. Overview
9.6.2. Oral Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. ANTIDIABETICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Antidiabetics Market Overview
10.1.2 North America Antidiabetics Market Forecasts and Analysis
10.1.3 North America Antidiabetics Market Forecasts and Analysis - By Product
10.1.4 North America Antidiabetics Market Forecasts and Analysis - By Patient Population
10.1.5 North America Antidiabetics Market Forecasts and Analysis - By Route of Administration
10.1.6 North America Antidiabetics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Antidiabetics Market
10.1.6.1.1 United States Antidiabetics Market by Product
10.1.6.1.2 United States Antidiabetics Market by Patient Population
10.1.6.1.3 United States Antidiabetics Market by Route of Administration
10.1.6.2 Canada Antidiabetics Market
10.1.6.2.1 Canada Antidiabetics Market by Product
10.1.6.2.2 Canada Antidiabetics Market by Patient Population
10.1.6.2.3 Canada Antidiabetics Market by Route of Administration
10.1.6.3 Mexico Antidiabetics Market
10.1.6.3.1 Mexico Antidiabetics Market by Product
10.1.6.3.2 Mexico Antidiabetics Market by Patient Population
10.1.6.3.3 Mexico Antidiabetics Market by Route of Administration
10.2. EUROPE
10.2.1 Europe Antidiabetics Market Overview
10.2.2 Europe Antidiabetics Market Forecasts and Analysis
10.2.3 Europe Antidiabetics Market Forecasts and Analysis - By Product
10.2.4 Europe Antidiabetics Market Forecasts and Analysis - By Patient Population
10.2.5 Europe Antidiabetics Market Forecasts and Analysis - By Route of Administration
10.2.6 Europe Antidiabetics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Antidiabetics Market
10.2.6.1.1 Germany Antidiabetics Market by Product
10.2.6.1.2 Germany Antidiabetics Market by Patient Population
10.2.6.1.3 Germany Antidiabetics Market by Route of Administration
10.2.6.2 France Antidiabetics Market
10.2.6.2.1 France Antidiabetics Market by Product
10.2.6.2.2 France Antidiabetics Market by Patient Population
10.2.6.2.3 France Antidiabetics Market by Route of Administration
10.2.6.3 Italy Antidiabetics Market
10.2.6.3.1 Italy Antidiabetics Market by Product
10.2.6.3.2 Italy Antidiabetics Market by Patient Population
10.2.6.3.3 Italy Antidiabetics Market by Route of Administration
10.2.6.4 Spain Antidiabetics Market
10.2.6.4.1 Spain Antidiabetics Market by Product
10.2.6.4.2 Spain Antidiabetics Market by Patient Population
10.2.6.4.3 Spain Antidiabetics Market by Route of Administration
10.2.6.5 United Kingdom Antidiabetics Market
10.2.6.5.1 United Kingdom Antidiabetics Market by Product
10.2.6.5.2 United Kingdom Antidiabetics Market by Patient Population
10.2.6.5.3 United Kingdom Antidiabetics Market by Route of Administration
10.2.6.6 Rest of Europe Antidiabetics Market
10.2.6.6.1 Rest of Europe Antidiabetics Market by Product
10.2.6.6.2 Rest of Europe Antidiabetics Market by Patient Population
10.2.6.6.3 Rest of Europe Antidiabetics Market by Route of Administration
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Antidiabetics Market Overview
10.3.2 Asia-Pacific Antidiabetics Market Forecasts and Analysis
10.3.3 Asia-Pacific Antidiabetics Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Antidiabetics Market Forecasts and Analysis - By Patient Population
10.3.5 Asia-Pacific Antidiabetics Market Forecasts and Analysis - By Route of Administration
10.3.6 Asia-Pacific Antidiabetics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Antidiabetics Market
10.3.6.1.1 Australia Antidiabetics Market by Product
10.3.6.1.2 Australia Antidiabetics Market by Patient Population
10.3.6.1.3 Australia Antidiabetics Market by Route of Administration
10.3.6.2 China Antidiabetics Market
10.3.6.2.1 China Antidiabetics Market by Product
10.3.6.2.2 China Antidiabetics Market by Patient Population
10.3.6.2.3 China Antidiabetics Market by Route of Administration
10.3.6.3 India Antidiabetics Market
10.3.6.3.1 India Antidiabetics Market by Product
10.3.6.3.2 India Antidiabetics Market by Patient Population
10.3.6.3.3 India Antidiabetics Market by Route of Administration
10.3.6.4 Rest of Asia-Pacific Antidiabetics Market
10.3.6.4.1 Rest of Asia-Pacific Antidiabetics Market by Product
10.3.6.4.2 Rest of Asia-Pacific Antidiabetics Market by Patient Population
10.3.6.4.3 Rest of Asia-Pacific Antidiabetics Market by Route of Administration
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Antidiabetics Market Overview
10.4.2 Middle East and Africa Antidiabetics Market Forecasts and Analysis
10.4.3 Middle East and Africa Antidiabetics Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Antidiabetics Market Forecasts and Analysis - By Patient Population
10.4.5 Middle East and Africa Antidiabetics Market Forecasts and Analysis - By Route of Administration
10.4.6 Middle East and Africa Antidiabetics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Antidiabetics Market
10.4.6.1.1 South Africa Antidiabetics Market by Product
10.4.6.1.2 South Africa Antidiabetics Market by Patient Population
10.4.6.1.3 South Africa Antidiabetics Market by Route of Administration
10.4.6.2 Saudi Arabia Antidiabetics Market
10.4.6.2.1 Saudi Arabia Antidiabetics Market by Product
10.4.6.2.2 Saudi Arabia Antidiabetics Market by Patient Population
10.4.6.2.3 Saudi Arabia Antidiabetics Market by Route of Administration
10.4.6.3 U.A.E Antidiabetics Market
10.4.6.3.1 U.A.E Antidiabetics Market by Product
10.4.6.3.2 U.A.E Antidiabetics Market by Patient Population
10.4.6.3.3 U.A.E Antidiabetics Market by Route of Administration
10.4.6.4 Rest of Middle East and Africa Antidiabetics Market
10.4.6.4.1 Rest of Middle East and Africa Antidiabetics Market by Product
10.4.6.4.2 Rest of Middle East and Africa Antidiabetics Market by Patient Population
10.4.6.4.3 Rest of Middle East and Africa Antidiabetics Market by Route of Administration
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Antidiabetics Market Overview
10.5.2 South and Central America Antidiabetics Market Forecasts and Analysis
10.5.3 South and Central America Antidiabetics Market Forecasts and Analysis - By Product
10.5.4 South and Central America Antidiabetics Market Forecasts and Analysis - By Patient Population
10.5.5 South and Central America Antidiabetics Market Forecasts and Analysis - By Route of Administration
10.5.6 South and Central America Antidiabetics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Antidiabetics Market
10.5.6.1.1 Brazil Antidiabetics Market by Product
10.5.6.1.2 Brazil Antidiabetics Market by Patient Population
10.5.6.1.3 Brazil Antidiabetics Market by Route of Administration
10.5.6.2 Argentina Antidiabetics Market
10.5.6.2.1 Argentina Antidiabetics Market by Product
10.5.6.2.2 Argentina Antidiabetics Market by Patient Population
10.5.6.2.3 Argentina Antidiabetics Market by Route of Administration
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTIDIABETICS MARKET, KEY COMPANY PROFILES
12.1. ELI LILLY COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BAYER CORPORATION AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. JOHNSON AND JOHNSON
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ASTRAZENECA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. PFIZER INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BRISTOL-MYERS SQUIBB
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVO NORDISK
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MERCK AND CO
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SANOFI
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Johnson & Johnson
2. Bayer Corporation AG
3. AstraZeneca
4. Sanofi
5. Novartis AG
6. Bristol-Myers Squibb Company
7. Merck & Co., Inc.
8. Eli Lilly and Company
9. Pfizer Inc.
10. Novo Nordisk
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For